Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol. 2022;33(1):27–63.

Article  PubMed  Google Scholar 

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26(1):1–133.

Article  PubMed  PubMed Central  Google Scholar 

Vogel J, Sekler J, Gückel B, Pfannenberg C, Nikolaou K, La Fougère C, et al. How [18F]FDG-PET/CT affects the management of patients with differentiated thyroid carcinoma in clinical routines. Cancers. 2024;16(3):588.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rosenbaum-Krumme SJ, Görges R, Bockisch A, Binse I. 18F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy. Eur J Nucl Med Mol Imaging. 2012;39(9):1373–80.

Article  PubMed  Google Scholar 

Yang JH, Maciel RMB, Nakabashi CCD, Janovsky CCPS, Padovani RP, Macellaro D, et al. Clinical utility of 18F-FDG PET/CT in the follow-up of a large cohort of patients with high-risk differentiated thyroid carcinoma. Arch Endocrinol Metab. 2017;61(5):416–25.

Article  PubMed  PubMed Central  Google Scholar 

Grawe F, Cahya A, Fabritius MP, Beyer L, Wenter V, Ruebenthaler J, et al. Course of Disease and Clinical Management of patients with poorly differentiated thyroid carcinoma. Cancers. 2021;13(21):5309.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Volante M, Lam AK, Papotti M, Tallini G. Molecular Pathology of poorly differentiated and anaplastic thyroid Cancer: what do pathologists need to know? Endocr Pathol. 2021;32(1):63–76.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Grabellus F, Nagarajah J, Bockisch A, Schmid KW, Sheu SY. Glucose transporter 1 expression, Tumor Proliferation, and Iodine/Glucose uptake in thyroid Cancer with emphasis on poorly differentiated thyroid carcinoma. Clin Nucl Med. 2012;37(2):121–7.

Article  PubMed  Google Scholar 

Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med off Publ Soc Nucl Med. 1996;37(9):1468–72.

CAS  Google Scholar 

Saif MW, Tzannou I, Makrilia N, Syrigos K. Role and cost effectiveness of PET/CT in management of patients with cancer. Yale J Biol Med. 2010;83(2):53–65.

PubMed  PubMed Central  Google Scholar 

Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG, et al. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer. 2003;97(5):1186–94.

Article  PubMed  Google Scholar 

De La Fouchardière C, Decaussin-Petrucci M, Berthiller J, Descotes F, Lopez J, Lifante JC, et al. Predictive factors of outcome in poorly differentiated thyroid carcinomas. Eur J Cancer. 2018;92:40–7.

Article  PubMed  Google Scholar 

Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose‐positron emission tomography‐positive thyroid carcinoma. Cancer. 2008;113(1):48–56.

Article  PubMed  Google Scholar 

Poisson T, Deandreis D, Leboulleux S, Bidault F, Bonniaud G, Baillot S, et al. 18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer. Eur J Nucl Med Mol Imaging. 2010;37(12):2277–85.

Article  PubMed  Google Scholar 

Thuillier P, Roudaut N, Crouzeix G, Cavarec M, Robin P, Abgral R, et al. Malignancy rate of focal thyroid incidentaloma detected by FDG PET–CT: results of a prospective cohort study. Endocr Connect. 2017;6(6):413–21.

Article  PubMed  PubMed Central  Google Scholar 

Piek MW, De Boer JP, Vriens MR, Van Leeuwaarde RS, Stokkel M, Hartemink KJ, et al. Retrospective analyses of 18 FDG-PET/CT thyroid incidentaloma in adults: incidence, treatment, and Outcome in a Tertiary Cancer Referral Center. Thyroid. 2021;31(11):1715–22.

Article  PubMed  CAS  Google Scholar 

Soelberg KK, Bonnema SJ, Brix TH, Hegedüs L. Risk of malignancy in thyroid Incidentalomas detected by 18 F-Fluorodeoxyglucose Positron Emission Tomography: a systematic review. Thyroid. 2012;22(9):918–25.

Article  PubMed  CAS  Google Scholar 

Bertagna F, Treglia G, Piccardo A, Giubbini R. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid Incidentalomas. J Clin Endocrinol Metab. 2012;97(11):3866–75.

Article  PubMed  CAS  Google Scholar 

Roddy S, Biggans T, Raofi AK, Kanodia A, Sudarshan T, Guntur Ramkumar P. Prevalence of incidental thyroid malignancy on routine 18F-fluorodeoxyglucose PET-CT in a large teaching hospital. Eur J Hybrid Imaging. 2020;4(1):21.

Article  PubMed  PubMed Central  Google Scholar 

Agrawal K, Weaver J, Ngu R, Krishnamurthy Mohan H. Clinical significance of patterns of incidental thyroid uptake at 18F-FDG PET/CT. Clin Radiol. 2015;70(5):536–43.

Article  PubMed  CAS  Google Scholar 

Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM, Nathan MA, et al. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med. 2007;48(6):896–901.

Article  PubMed  CAS  Google Scholar 

De Leijer JF, Metman MJH, Van Der Hoorn A, Brouwers AH, Kruijff S, Van Hemel BM, et al. Focal thyroid incidentalomas on 18F-FDG PET/CT: a systematic review and Meta-analysis on prevalence, risk of malignancy and inconclusive fine needle aspiration. Front Endocrinol. 2021;12:723394.

Article  Google Scholar 

Scappaticcio L, Piccardo A, Treglia G, Poller DN, Trimboli P. The dilemma of 18F-FDG PET/CT thyroid incidentaloma: what we should expect from FNA. A systematic review and meta-analysis. Endocrine. 2021;73(3):540–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 2014;81(s1):1–122.

Article  PubMed  CAS  Google Scholar 

Jarząb B, Dedecjus M, Lewiński A, Adamczewski Z, Bakuła-Zalewska E, Bałdys-Waligórska A, the National Oncological Strategy. Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and. 2022 Update. Endokrynol Pol. 2022;73(2):173–300.

Durante C, Hegedüs L, Czarniecka A, Paschke R, Russ G, Schmitt F, et al. 2023 European thyroid Association Clinical Practice guidelines for thyroid nodule management. Eur Thyroid J. 2023;12(5):e230067.

Article  PubMed  PubMed Central  Google Scholar 

Wadsley J, Balasubramanian SP, Madani G, Munday J, Roques T, Rowe CW et al. Consensus statement on the management of incidentally discovered FDG avid thyroid nodules in patients being investigated for other cancers. Clin Endocrinol (Oxf). 2023;cen.14905.

Pattison DA, Bozin M, Gorelik A, Hofman MS, Hicks RJ, Skandarajah A. 18 F-FDGthyroidhincidentalomasalthesimportancertance of Contextual Interpretation. J Nucl Med. 2018;59(5):749–55.

Article  PubMed  Google Scholar 

Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA. The 2023 Bethesda System for Reporting Thyroid Cytopathology. Thyroid®. 2023;thy.2023.0141.

Vuong HG, Ngo HTT, Bychkov A, Jung CK, Vu TH, Lu KB, et al. Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between western and Asian countries: a systematic review and meta-analysis. Cancer Cytopathol. 2020;128(4):238–49.

Article  PubMed  Google Scholar 

Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda System for reporting thyroid cytopathology: a Meta-analysis. Acta Cytol. 2012;56(4):333–9.

Article  PubMed  Google Scholar 

De Koster EJ, De Geus-Oei LF, Brouwers AH, Van Dam EWCM, Dijkhorst-Oei LT, Van Engen-van Grunsven ACH, et al. [18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial. Eur J Nucl Med Mol Imaging. 2022;49(6):1970–84.

Article  PubMed  PubMed Central  Google Scholar 

Piccardo A, Puntoni M, Dezzana M, Bottoni G, Foppiani L, Marugo A, et al. Indeterminate thyroid nodules. The role of 18F-FDG PET/CT in the era of ultrasonography risk stratification systems and new thyroid cytology classifications. Endocrine. 2020;69(3):553–61.

Article  PubMed  CAS  Google Scholar 

Rosario PW, Rocha TG, Calsolari MR. Fluorine-18-fluorodeoxyglucose positron emission tomography in thyroid nodules with indeterminate cytology: a prospective study. Nucl Med Commun. 2019;40(2):185–7.